IIPP in the media: May 2019
10 May 2019
IIPP's research, work and people are regularly featured in the media around the world. Here is a round-up of cover achieved in May 2019.

Transformation Capital: A new investment logic for catalysing systems change (25 May, Climate-Kic)
Silicon Valley-style investment was not an inevitable outcome of market economics, nor is it necessarily the model of the future (22 May 2019, Julius Krein)
How can we meet the “grand challenges” of our time without bypassing democracy? (22 May 2019, Peter McColl)
No wonder the real estate agents went against Labor, Crikey Australia (23 May 2019, Ian Mcauley)
Let's make sure politicians know value of research, The Australian (23 May 2019, Duncan Ivison)
TEDSummit 2019 speaker line-up, TedSummit Report (21 May 2019, TedSummit)
City AM article about British Steel quoting MOIIS report & how transformation of seel industry is necessary, Public Finance (20 May 2019, Christian May)
Public Finance article quoting Mariana about how the Scottish bank shouldn't have their funding regulated, Public Finance (20 May 2019, Kerry Lorimer)
Marco Rubio Puts out a paper citing obscure Left-Wing Economists, Bloomberg (16 May 2019, James Redmond)
The value of everything interview, (9 May 2019, Letra Libres, El valor de Mariana Mazzucato)
Architetti nella pubblica amministrazione. Dal Regno Unito l’esperienza di Public Practice, Artribune (7 May 2019, Finn Williams)
The role of the state in creating economic value, The Economist (9 May 2019, Mariana Mazzucato)
UCL professor Mariana Mazzucato receives the 2019 Madame de Staël Prize, Science Business (9 May 2019, Mariana Mazzucato)
Der Überwachungkapitalismus bedroht die FreiheitVom Schöpfen und Abschöpfen, Der Tagesspiegel (7 May 2019, Mariana Mazzucato)
The Reader: Bank of England’s next boss must think outside of the box, Evening Standard (7 May 2019, Mariana Mazzucato, Josh Ryan-Collins)
El valor de Mariana Mazzucato, Letra Libres (6 May 2019, Mariana Mazzucato)
- Investors Chronicle: Greene King, Standard Chartered, GlaxoSmithKline, Financial Times (3 May 2019, Josh Ryan-Collins)